Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 09:07 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease
NCT00351364 · University of Calgary · PHASE4 · terminated · last registry update 2014-12-03 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Diffic;ulty recruiting” | – | Registry record, University of Calgary |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CYSLTR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2015-09-04Phase 3 first posted: Hormozgan University of Medical Sciences, Monteleukast + Mometasone (NCT02541760)
- 2015-07-08Results posted on the registry: AstraZeneca, Roflumilast + Roflumilast placebo (NCT01765192)
- 2015-06-29Phase 3 first posted: GlaxoSmithKline, FF + Placebo (NCT02483975)
- 2015-06-19Results posted on the registry: Medical College of Wisconsin, montelukast sodium (NCT00863317)
- 2014-12-09Results posted on the registry: 1st Allergy & Clinical Research Center, Montelukast + Placebo (NCT00557284)
- 2014-11-17Results posted on the registry: Duke University, Montelukast (NCT01016847)
- 2014-11-17Also stopped (terminated): Duke University, Montelukast (NCT01016847)
- 2014-11-14Results posted on the registry: Organon and Co, Montelukast 10 mg/loratadine 10 mg + Placebo (NCT01673620)
- 2014-10-23Also stopped (terminated): Universitaire Ziekenhuizen KU Leuven, Montelukast + long acting beta2 mimetic (NCT01224964)
- 2014-10-21Results posted on the registry: Penn State University, montelukast + placebo (NCT00590772)
- 2014-10-17Results posted on the registry: Deborah Gentile, Montelukast + Placebo (NCT00189475)
- 2014-10-15Results posted on the registry: Genentech, Inc., Omalizumab + Placebo (NCT01125748)
- 2014-10-08Results posted on the registry: Deborah Gentile, Montelukast + Placebo (NCT00189462)
- 2014-09-29Results posted on the registry: Organon and Co, Montelukast Oral Granules (OG) + Montelukast Chewable Tablets (CT) (NCT01852812)
- 2014-05-26Results posted on the registry: Organon and Co, Montelukast + Placebo (NCT01857063)
- 2014-04-04Phase 3 first posted: Hoffmann-La Roche, Lebrikizumab + Montelukast (NCT02104674)
- 2014-02-28Also stopped (terminated): University of Chicago, Placebo + Montelukast (NCT00119015)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision